Willemien C. van Dijk

1000 citations

28 papers · 810 indexed · h-index 17

Microbiology top 5%
- Reproductive tract infections research 3
- Bacterial Infections and Vaccines 3
Endocrinology top 10%
- Escherichia coli research studies 4
Hepatology top 10%
Immunology
Epidemiology top 10%
Infectious Diseases
- Clostridium difficile and Clostridium perfringens research 4
- HIV/AIDS drug development and treatment 3
Oncology
- Neutropenia and Cancer Infections 3
Public Health, Environmental and Occupational Health
- Streptococcal Infections and Treatments 3
Virology
- HIV Research and Treatment 2

Co-authors: J. Verhoef Henri A. Verbrugh R. Peters Marijke E. van der Tol Phillip K. Peterson J. Lindeman Paul Herbrink Anton M. van Loon
Cited by: Microbiology Endocrinology Hepatology
Journals: Journal of Clinical Microbiology (4 papers)European Journal of Clinical Microbiology & Infectious Diseases (3 papers)The Journal of Infectious Diseases (3 papers)
Partner nations: Netherlands United States Guinea-Bissau

In The Last Decade

Willemien C. van Dijk

28 papers receiving 718 citations

Peers

Countries citing papers authored by Willemien C. van Dijk

Since Specialization

Citations

This map shows the geographic impact of Willemien C. van Dijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willemien C. van Dijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willemien C. van Dijk more than expected).

Fields of papers citing papers by Willemien C. van Dijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willemien C. van Dijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willemien C. van Dijk. The network helps show where Willemien C. van Dijk may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Willemien C. van Dijk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Willemien C. van Dijk Line = papers co-authored together Willemien C. van Dijk links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Value of Different Assays for Detection of Human Cytomegalovirus (HCMV) in Predicting the Development of HCMV Disease in Human Immunodeficiency Virus-Infected Patients Journal of Clinical Microbiology ·Elizabeth Santiago del Angel,Pieter L. Meenhorst,Jan W. Mulder,Gerrit Jan Weverling,Hein Putter,W. Pauw,Willemien C. van Dijk,Paul H.M. Smits,Marcos Vaqueiro Rodríguez,Peter Reiss,Joep M. A. Lange	2000	23
2	At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies Annals of Oncology ·Anneke M. Westermann,Chris Melzer,Rh Menia,L. van Leeuwen,Emanuel J.M. Willemse,Willemien C. van Dijk,W J Nooijen,Joke W. Baars,Jan H. Schornagel,Sjoerd Rodenhuis	1999	29
3	Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients AIDS ·Elizabeth Santiago del Angel,Pieter L. Meenhorst,Gerrit Jan Weverling,H Einsele,W. Pauw,Jan W. Mulder,Willemien C. van Dijk,Paul H.M. Smits,Joep M. A. Lange	1999	5
4	Comparative in-vitro activity of meropenem against selected pathogens from hospitalized patients in The Netherlands. MASTIN Study Group Journal of Antimicrobial Chemotherapy ·Hubert P. Endtz,Willemien C. van Dijk,H.A. Verbrugh	1997	8
5	Gastric Non-Hodgkin Lymphomas of Mucosa-Associated Lymphoid Tissue Are not Associated With More AggressiveHelicobacter pyloriStrains as Identified by CagA American Journal of Clinical Pathology ·Daphne de Jong,René W. van der Hulst,Gerard Pals,Willemien C. van Dijk,Arie van der Ende,G N Tytgat,Babs G. Taal,Henk Boot	1996	40
6	Prevalence of antibodies to hepatitis C virus in a Dutch group of haemodialysis patients related to risk factors Journal of Hospital Infection ·Peter M. Schneeberger,Zheng Gengxiu,Willemien C. van Dijk	1993	10
7	Detection ofChlamydia trachomatis in clinical specimens by the polymerase chain reaction European Journal of Clinical Microbiology & Infectious Diseases ·Zhang Fei-ju,Willem J. G. Melchers,Wu MeiShuang,多麻男斎藤,Willemien C. van Dijk,J. Lindeman,Wim Quint	1990	76
8	Serodiagnosis of respiratory syncytial virus (RSV) infection in children as measured by detection of RSV-specific immunoglobulins G, M, and A with enzyme-linked immunosorbent assay Journal of Clinical Microbiology ·Dewa Putu Agus Wahyu Erawan,Paul Herbrink,J. Lindeman,Willemien C. van Dijk	1990	13
9	Favourable Effect of Detergent on Antigen Detection and Comparison of Enzyme Linked Detection Systems in an Elisa forChlamydia Trachomatis Journal of Immunoassay ·L. Arnold Noorduyn,Dewa Putu Agus Wahyu Erawan,J. Lindeman,Willemien C. van Dijk,Paul Herbrink	1989	4
10	Human serum antibody response inCampylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay European Journal of Clinical Microbiology & Infectious Diseases ·Paul Herbrink,Guo Qilin,Thomas D. Dulaney,J. Lindeman,Willemien C. van Dijk	1988	33
11	Detection of Chlamydia trachomatis in culture and urogenital smears by in situ DNA hybridization using a biotinylated DNA probe Molecular and Cellular Probes ·Dewa Putu Agus Wahyu Erawan,W G Quint,T. Nesterova,Edilson Leite de Sousa,Willemien C. van Dijk,J. Lindeman,Paul Herbrink	1988	10
12	Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii Journal of Clinical Microbiology ·Paul Herbrink,Anton M. van Loon,J.P. Rotmans,F. van Knapen,Willemien C. van Dijk	1987	34
13	Induction of the Early Hypotensive Phase by Escherichia coli: Role of Bacterial Surface Structures and Inflammatory Mediators The Journal of Infectious Diseases ·J.V. Turégano Pastor,Mohammad Nasir Hemmatian,Willemien C. van Dijk,Frans P. Nijkamp,Wybren de Jong,J. Verhoef	1985	2
14	Contact activation by bacterial fragments Inflammation Research ·Harini S Rajaraman,Willemien C. van Dijk,Ans Timmermans,J. Verhoef,Bonno N. Bouma	1983	1
15	Effect of influenza viras on phagocytic cells European Journal of Clinical Microbiology & Infectious Diseases ·Y. J. Debets-Ossenkopp,Elaine L. Mills,Willemien C. van Dijk,Henri A. Verbrugh,J. Verhoef	1982	17
16	The effect of influenza virus on human polymorphonuclear leukocytes Antonie van Leeuwenhoek ·Y. J. Debets-Ossenkopp,Willemien C. van Dijk,Elaine L. Mills,Henri A. Verbrugh,J. Verhoef	1980	5
17	Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2. PubMed ·Henri A. Verbrugh,Willemien C. van Dijk,R. Peters,Rodolfo Nuñez Miller,Phillip K. Peterson,J. Verhoef	1979	28
18	Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization Infection and Immunity ·Willemien C. van Dijk,Henri A. Verbrugh,Marijke E. van der Tol,R. Peters,J. Verhoef	1979	59
19	Quantitation of the Third Component of Human Complement Attached to the Surface of Opsonized Bacteria: Opsonin-Deficient Sera and Phagocytosis-Resistant Strains Infection and Immunity ·Henri A. Verbrugh,Willemien C. van Dijk,Puning Liu,R.C. Peters,Phillip K. Peterson,J. Verhoef	1979	35
20	The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization. PubMed ·Henri A. Verbrugh,Willemien C. van Dijk,R. Peters,Marijke E. van der Tol,J. Verhoef	1979	51

About Willemien C. van Dijk

Willemien C. van Dijk is a scholar working on Microbiology, Endocrinology, Virology, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 28 papers that have together received 810 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (4 papers), Escherichia coli research studies (4 papers), Reproductive tract infections research (3 papers), Neutropenia and Cancer Infections (3 papers), Streptococcal Infections and Treatments (3 papers), Bacterial Infections and Vaccines (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Microbiology (155 citations), Endocrinology (69 citations), Hepatology (103 citations), Immunology (208 citations) and Epidemiology (322 citations). Willemien C. van Dijk has collaborated with scholars based in Netherlands, United States and Guinea-Bissau. Frequent co-authors include J. Verhoef, Henri A. Verbrugh, R. Peters, Marijke E. van der Tol, Phillip K. Peterson, J. Lindeman, Paul Herbrink, Anton M. van Loon, Bonno N. Bouma and Peter M. Schneeberger. Their work appears in journals such as Journal of Clinical Microbiology, European Journal of Clinical Microbiology & Infectious Diseases, The Journal of Infectious Diseases, Infection and Immunity and Journal of Medical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact